# US 2026/0297140 A1 · Immunoglobulin-binding protein

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2026/0297140 A1
- Document ID: US20260297140A1
- Status: Published application
- Kind: A1
- Application number: 19/477,598
- Filed: 2024-04-18
- Published: 2026-10-01
- Earliest claimed: 2023-04-24
- Assignees: Tosoh Corporation
- Applicants: Tosoh Corporation
- Inventors: Takatoshi HASEMI; Akihiro IWASE; Kazuki AIDA; Toru TANAKA
- Web page: https://patentgrep.com/patent/US20260297140A1

## CPC

- C07K 14/195: from bacteria
- B01D 15/3809: {of the antigen-antibody type, e.g. protein A, G or L chromatography}
- B01J 20/24: Naturally occurring macromolecular compounds, e.g. humic acids or their derivatives
- B01J 20/288: Polar phases
- C12N 15/70: Vectors or expression systems specially adapted for E. coli
- B01J 2220/52: Sorbents specially adapted for preparative chromatography
- C07K: PEPTIDES (peptides in foodstuffs A23; obtaining protein compositions for foodstuffs, working-up proteins for foodstuffs A23J; preparations for medicinal purposes A61K; peptides containing beta-lactam rings C07D; cyclic dipeptides not having in their molecule any other peptide link than those which form their ring, e.g. piperazine-2,5-diones, C07D; ergot alkaloids of the cyclic peptide type C07D519/02; macromolecular compounds having statistically distributed amino acid units in their molecules, i.e. when the preparation does not provide for a specific; but for a random sequence of the amino acid units, homopolyamides and block copolyamides derived from amino acids C08G69/00; macromolecular products derived from proteins C08H1/00; preparation of glue or gelatine C09H; single cell proteins, enzymes C12N; genetic engineering processes for obtaining peptides C12N15/00; compositions for measuring or testing processes involving enzymes C12Q; investigation or analysis of biological material G01N33/00)
- B01D: SEPARATION (separating solids from solids by wet methods B03B, B03D; by pneumatic jigs or tables B03B; by other dry methods B07; magnetic or electrostatic separation of solid materials from solid materials or fluids, separation by high-voltage electric fields B03C; centrifuges, vortex apparatus B04; presses per se for squeezing-out liquid from liquid-containing material B30B9/02; treatment of water C02F, e.g. softening by ion-exchange C02F1/42; {arrangements of air intake cleaners in gas turbine plants F02C7/05} ; arrangements or mounting of filters in air-conditioning, air-humidification or ventilation F24F13/28)
- B01J: CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- C12N: MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media C12Q1/00)

## Abstract

A protein includes an amino acid sequence of an immunoglobulin-binding domain of Protein L derived from bacterium of the genus Finegoldia, provided that in the amino acid sequence, the protein has one or more amino acid substitutions selected from at least (1)-(5) below, the protein having immunoglobulin-binding activity: (1) substitution of amino acid residue corresponding to tyrosine at position 42 of SEQ ID NO: 1 with histidine; (2) substitution of amino acid residue corresponding to lysine at position 22 of SEQ ID NO: 1 with glutamic acid; (3) substitution of amino acid residue corresponding to lysine at position 38 of SEQ ID NO: 1 with proline or aspartic acid; (4) substitution of amino acid residue corresponding to tyrosine at position 42 of SEQ ID NO: 1 with tryptophan or phenylalanine; and (5) substitution of amino acid residue corresponding to asparagine at position 44 of SEQ ID NO: 1 with proline.

## Claims

### Claim 1

A protein comprising an amino acid sequence of an immunoglobulin-binding domain of Protein L derived from a bacterium of the genus Finegoldia, provided that in the amino acid sequence, the protein has one or more amino acid substitutions selected from at least (1) to (5) below, the protein having immunoglobulin-binding activity:
(1) substitution of an amino acid residue corresponding to tyrosine at position 42 of SEQ ID NO: 1 with histidine;
(2) substitution of an amino acid residue corresponding to lysine at position 22 of SEQ ID NO: 1 with glutamic acid;
(3) substitution of an amino acid residue corresponding to lysine at position 38 of SEQ ID NO: 1 with proline or aspartic acid;
(4) substitution of an amino acid residue corresponding to tyrosine at position 42 of SEQ ID NO: 1 with tryptophan or phenylalanine; and
(5) substitution of an amino acid residue corresponding to asparagine at position 44 of SEQ ID NO: 1 with proline.

### Claim 2 (depends on 1)

The protein according to claim 1, wherein the protein is a protein as described in any of (a) to (c) below:
(a) a protein including an amino acid sequence set forth in SEQ ID NO: 1, provided that in the amino acid sequence, the protein has one or more amino acid substitutions selected from at least (1) to (5) below, the protein having immunoglobulin-binding activity:
(1) substitution of an amino acid residue corresponding to tyrosine at position 42 of SEQ ID NO: 1 with histidine;
(2) substitution of an amino acid residue corresponding to lysine at position 22 of SEQ ID NO: 1 with glutamic acid;
(3) substitution of an amino acid residue corresponding to lysine at position 38 of SEQ ID NO: 1 with proline or aspartic acid;
(4) substitution of an amino acid residue corresponding to tyrosine at position 42 of SEQ ID NO: 1 with tryptophan or phenylalanine; and
(5) substitution of an amino acid residue corresponding to asparagine at position 44 of SEQ ID NO: 1 with proline;
(b) a protein including an amino acid sequence set forth in SEQ ID NO: 1, provided that in the amino acid sequence, the protein has one or more amino acid substitutions selected from at least the (1) to (5) and also includes one or several substitutions, deletions, insertions and/or additions of amino acid residues at one or several positions in addition to the (1) to (5), the protein having immunoglobulin-binding activity; and
(c) a protein including an amino acid sequence having a homology of 70% or more to an amino acid sequence set forth in SEQ ID NO: 1 or a partial sequence thereof, provided that in the amino acid sequence, the protein has one or more amino acid substitutions selected from at least the (1) to (5), the protein having immunoglobulin-binding activity.

### Claim 3 (depends on 1)

The protein according to claim 1, further comprising at least one or more amino acid substitutions selected from (6) to (11) below:
(6) substitution of an amino acid residue corresponding to asparagine at position 50 of SEQ ID NO: 1 with tyrosine;
(7) substitution of an amino acid residue corresponding to glutamic acid at position 4 of SEQ ID NO: 1 with glycine;
(8) substitution of an amino acid residue corresponding to lysine at position 7 of SEQ ID NO: 1 with alanine;
(9) substitution of an amino acid residue corresponding to glutamic acid at position 52 of SEQ ID NO: 1 with leucine;
(10) substitution of an amino acid residue corresponding to tyrosine at position 53 of SEQ ID NO: 1 with phenylalanine; and
(11) substitution of an amino acid residue corresponding to alanine at position 69 of SEQ ID NO: 1 with valine.

### Claim 4 (depends on 1)

The protein according to claim 1, further comprising at least an amino acid substitution of (6) below and one or more amino acid substitutions selected from (7) to (11) below:
(6) substitution of an amino acid residue corresponding to asparagine at position 50 of SEQ ID NO: 1 with tyrosine;
(7) substitution of an amino acid residue corresponding to glutamic acid at position 4 of SEQ ID NO: 1 with glycine;
(8) substitution of an amino acid residue corresponding to lysine at position 7 of SEQ ID NO: 1 with alanine;
(9) substitution of an amino acid residue corresponding to glutamic acid at position 52 of SEQ ID NO: 1 with leucine;
(10) substitution of an amino acid residue corresponding to tyrosine at position 53 of SEQ ID NO: 1 with phenylalanine; and
(11) substitution of an amino acid residue corresponding to alanine at position 69 of SEQ ID NO: 1 with valine.

### Claim 5 (depends on 1)

The protein according to claim 1, further comprising at least an amino acid substitution of (12) below:
(12) substitution of an amino acid residue corresponding to lysine at position 29 of SEQ ID NO: 1 with isoleucine.

### Claim 6 (depends on 4)

The protein according to claim 4, wherein the protein is a protein as described in any of (d) to (f) below:
(d) a protein including an amino acid sequence set forth in SEQ ID NO: 70, provided that in the amino acid sequence, the protein has one or more amino acid substitutions selected from at least (1) to (5) below, the protein having immunoglobulin-binding activity:
(1) substitution of an amino acid residue corresponding to tyrosine at position 42 of SEQ ID NO: 1 with histidine;
(2) substitution of an amino acid residue corresponding to lysine at position 22 of SEQ ID NO: 1 with glutamic acid;
(3) substitution of an amino acid residue corresponding to lysine at position 38 of SEQ ID NO: 1 with proline or aspartic acid;
(4) substitution of an amino acid residue corresponding to tyrosine at position 42 of SEQ ID NO: 1 with tryptophan or phenylalanine; and
(5) substitution of an amino acid residue corresponding to asparagine at position 44 of SEQ ID NO: 1 with proline;
(e) a protein including an amino acid sequence set forth in SEQ ID NO: 70, provided that in the amino acid sequence, the protein has one or more amino acid substitutions selected from at least the (1) to (5) and also includes one or several substitutions, deletions, insertions and/or additions of amino acid residues at one or several positions in addition to the (1) to (5), the protein having immunoglobulin-binding activity; and
(f) a protein including an amino acid sequence having a homology of 70% or more to an amino acid sequence set forth in SEQ ID NO: 70 or a partial sequence thereof, provided that in the amino acid sequence, the protein has one or more amino acid substitutions selected from at least the (1) to (5), the protein having immunoglobulin-binding activity.

### Claim 7 (depends on 1)

A polynucleotide encoding the protein according to claim 1.

### Claim 8 (depends on 7)

An expression vector comprising the polynucleotide according to claim 7.

### Claim 9 (depends on 1)

A recombinant host comprising (A) or (B) below:
(A) a polynucleotide encoding the protein according to claim 1; or
(B) an expression vector including a polynucleotide encoding the protein.

### Claim 10 (depends on 9)

The recombinant host according to claim 9, wherein the host is Escherichia coli.

### Claim 11 (depends on 1)

A method for manufacturing a protein having immunoglobulin-binding activity, the method comprising culturing a recombinant host including a polynucleotide encoding the protein according to claim 1 or a recombinant host including an expression vector including the polynucleotide to allow the protein to be expressed and a step of recovering the expressed protein.

### Claim 12 (depends on 11)

The manufacturing method according to claim 11, wherein the host is Escherichia coli.

### Claim 13 (depends on 1)

An immunoglobulin adsorbent comprising an insoluble support and the protein according claim 1 immobilized on the insoluble support.

### Claim 14 (depends on 13)

A method for separating an immunoglobulin contained in a solution, the method comprising applying a solution containing the immunoglobulin to a column packed with the adsorbent according to claim 13 to allow the immunoglobulin to be adsorbed onto the adsorbent and eluting the immunoglobulin adsorbed on the adsorbent.
